Make critical decisions with confidence

• Elucidate disease mechanisms by characterizing native or recombinant protein interactions
• Select the best antibodies as research tools, assay components or therapeutics by fully defining their interaction behavior
• Define potential drug targets and diagnostic markers
• Develop assays to characterize protein: LMW compound interactions in drug development
• Select protein therapeutic candidates according to their on/off rates
• Detect and characterize immune responses during preclinical and clinical development
• Characterize protein therapeutics and implement QC methods

Key performance benefits

• Analyze up to 384 samples per run, automatically
• Analyze over the broadest kinetic range
• Use software wizards for fast assay development, analysis and evaluation of every interaction parameter: kinetics, affinity, specificity, concentration, thermodynamics
• Support for assay development, analysis and evaluation when working with LMW compounds <1000 Da
• Use buffer scouting for fast assay development
• Use integrated buffer degassing to improve robustness when studying interactions at elevated temperatures 
• Use integrated sample cooling for temperature-sensitive samples